Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2023-03-20 Regulatory Filings
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(담도암 치료제 HDB001A의 식품의약품안전처 제 2/3상 임상시험계획 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Handok) regarding a 'Major Management Matter' (주요경영사항), specifically the submission of a Phase 2/3 clinical trial application for a biliary tract cancer treatment (HDB001A) to the Ministry of Food and Drug Safety. This type of disclosure is a standard regulatory announcement for material corporate events that do not fall into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a Regulatory Filing (RNS).
2023-03-20 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 65th fiscal year (2022) of HANDOK Inc. It contains comprehensive financial data, company overview, management discussion, and governance details, which is the standard format for an Annual Report in the Korean regulatory context (DART system). It is not an announcement or a summary, but the full report itself. FY 2022
2023-03-16 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of 'Share Issue/Capital Change' (SHA) in the provided classification schema.
2023-03-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Correction Report). It details the issuance of stock options to employees, including specific terms, exercise prices, and beneficiary lists. This type of corporate disclosure regarding capital structure and equity-based compensation falls under the category of Regulatory Filings (RNS) as it is a specific corporate announcement required by the financial authorities (Financial Services Commission/Korea Exchange) that does not fit into more specific categories like M&A or Dividend notices.
2023-03-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously granted stock options, including the cancellation of some options and adjustments to the number of recipients and shares. This type of filing is a standard regulatory disclosure regarding capital structure and employee compensation instruments, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2023-03-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Correction Report). It details changes to previously granted stock options, including adjustments to the number of shares and the list of recipients. This type of filing is a standard corporate disclosure regarding capital structure and equity-based compensation, which falls under the category of Regulatory Filings (RNS) as it is a specific corporate announcement submitted to the financial authorities.
2023-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.